Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This is an open label, single center, randomized, active comparator controlled study,
comparing the effects of vitamin D replacement using oral ergocalciferol versus paricalcitol
on parathyroid hormone (PTH) levels in patients with stage 3 and 4 CKD and vitamin D
deficiency or insufficiency. The purpose of this study is to determine which of these two
approaches is more successful.